OC-046Acetic Acid Chromoscopy Significantly Improves Neoplasia Detection Rates as compared to Cleveland Clinic Protocol during Barrett'S Surveillance

IntroductionCost effectiveness of Barrett's surveillance has recently being questioned due to the low neoplasia detection rate. Acetic acid chromoscopy (AAC) has been shown to improve neoplasia detection in Barrett's oesophagus but not in surveillance population. The aim of this study is t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gut 2013-06, Vol.62 (Suppl 1), p.A20-A21
Hauptverfasser: Bhattacharyya, R, Tholoor, S, Longcroft-Wheaton, G, Basford, P, Cowlishaw, D, Poller, D, Bhandari, P
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page A21
container_issue Suppl 1
container_start_page A20
container_title Gut
container_volume 62
creator Bhattacharyya, R
Tholoor, S
Longcroft-Wheaton, G
Basford, P
Cowlishaw, D
Poller, D
Bhandari, P
description IntroductionCost effectiveness of Barrett's surveillance has recently being questioned due to the low neoplasia detection rate. Acetic acid chromoscopy (AAC) has been shown to improve neoplasia detection in Barrett's oesophagus but not in surveillance population. The aim of this study is to compare the effectiveness of AAC with Cleveland clinic protocol (2 cm quadrantic) guided biopsies at detecting high risk neoplasia during Barrett's surveillance.MethodsProspective Cohort study comparing two different Barrett's surveillance strategies. All patients who underwent Barrett's surveillance between 2008-12 were recorded on a Barrett's database. All neoplasias were independently reviewed by two GI Pathologists. Barrett's surveillance patients were randomly allocated to acetic acid chromoscopy lists (cohort B) or protocol guided biopsy (Cohort A) lists. AAC involved targeted biopsy of area of concern & 3 additional biopsies from lower, middle & top end of Barrett's. Protocol guided were taken as quadrantic biopsies every 2 cm & any visible abnormality. Fisher's exact test was used for statistical analysis.ResultsN = 982 Barrett's surveillance gastroscopy between 2008-12. Median age was 66 years & Median Barrett's length was 4.5 cm (range: 1-20). Male: Female = 3.3:1.Protocol guided Cohort AN = 655/982(66.7%). 7/655 (1%) patients were found to have high grade dysplasia (HGD) & 3/655(0.4%) had T-1 cancers with an overall high risk neoplasia detection rate of 10/655(1.5%).Acetic acid Cohort BN = 327/982(33.2%). 18/327(5.5%) patients were found to have HGD & 14/327(4.2%) had T-1 cancers with an overall high risk neoplasia detection rate of 32/327(9.7%). This shows a statistically significant 6.5 fold (p = 0.0001) increased detection of high risk neoplasia with acetic acid guided biopsies as compared to protocol guided biopsies in Barrett's surveillance.Abstract OC-046 Table 1Protocol biopsies cohort(Cohort A)AAC cohort(Cohort B)N=655N=327Gainp valueHGD7/655(1.0%)18/327 (5.5%)5.5 fold0.0001T1 Cancers3/655 (0.4%)14/327 (4.2%)10 fold0.0001Total10/655 (1.5%)32/327 (9.7%)6.5 fold0.0001ConclusionThis is the first report from a large exclusively Barrett's surveillance population. Our data demonstrates that acetic acid chromoscopy significantly (6.5 fold) improves the detection of high risk neoplasia in Barrett's surveillance as compared to the current standard of 2 cm quadrantic biopsies. AAC also results in significantly less number of biopsies taken so overall it will be
doi_str_mv 10.1136/gutjnl-2013-304907.045
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_1753468454</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1753468454</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_17534684543</originalsourceid><addsrcrecordid>eNqVjTtOxDAURV2AxPDZAnodNB5s4vzKIYCgAUToR5bzJnjk-AXbiTQLYb8EiQ1Q3eIencPYpRRrKbPipp_S3jt-K2TGM6FqUa6Fyo_YSghZ8rxU9Qk7jXEvhKiqWq7Y92vDhSo2BpM1sDG2g-Yz0EDR0HiA1vbe7qzRPrkDPA9joBkjvCCNTker4R4TmmTJw7tOy6MjGBpGHbCDRNA4nNFpv1id9UvhLVAiQw66KVjfw50OAVO6aqGdwozWLbDBc3a80y7ixd-esevHh4_miS_9rwlj2g42GvyFkaa4lWWeqaJSucr-gf4Ak_Zi3g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1753468454</pqid></control><display><type>article</type><title>OC-046Acetic Acid Chromoscopy Significantly Improves Neoplasia Detection Rates as compared to Cleveland Clinic Protocol during Barrett'S Surveillance</title><source>PubMed (Medline)</source><source>BMJ Journals Online Archive</source><creator>Bhattacharyya, R ; Tholoor, S ; Longcroft-Wheaton, G ; Basford, P ; Cowlishaw, D ; Poller, D ; Bhandari, P</creator><creatorcontrib>Bhattacharyya, R ; Tholoor, S ; Longcroft-Wheaton, G ; Basford, P ; Cowlishaw, D ; Poller, D ; Bhandari, P</creatorcontrib><description><![CDATA[IntroductionCost effectiveness of Barrett's surveillance has recently being questioned due to the low neoplasia detection rate. Acetic acid chromoscopy (AAC) has been shown to improve neoplasia detection in Barrett's oesophagus but not in surveillance population. The aim of this study is to compare the effectiveness of AAC with Cleveland clinic protocol (2 cm quadrantic) guided biopsies at detecting high risk neoplasia during Barrett's surveillance.MethodsProspective Cohort study comparing two different Barrett's surveillance strategies. All patients who underwent Barrett's surveillance between 2008-12 were recorded on a Barrett's database. All neoplasias were independently reviewed by two GI Pathologists. Barrett's surveillance patients were randomly allocated to acetic acid chromoscopy lists (cohort B) or protocol guided biopsy (Cohort A) lists. AAC involved targeted biopsy of area of concern & 3 additional biopsies from lower, middle & top end of Barrett's. Protocol guided were taken as quadrantic biopsies every 2 cm & any visible abnormality. Fisher's exact test was used for statistical analysis.ResultsN = 982 Barrett's surveillance gastroscopy between 2008-12. Median age was 66 years & Median Barrett's length was 4.5 cm (range: 1-20). Male: Female = 3.3:1.Protocol guided Cohort AN = 655/982(66.7%). 7/655 (1%) patients were found to have high grade dysplasia (HGD) & 3/655(0.4%) had T-1 cancers with an overall high risk neoplasia detection rate of 10/655(1.5%).Acetic acid Cohort BN = 327/982(33.2%). 18/327(5.5%) patients were found to have HGD & 14/327(4.2%) had T-1 cancers with an overall high risk neoplasia detection rate of 32/327(9.7%). This shows a statistically significant 6.5 fold (p = 0.0001) increased detection of high risk neoplasia with acetic acid guided biopsies as compared to protocol guided biopsies in Barrett's surveillance.Abstract OC-046 Table 1Protocol biopsies cohort(Cohort A)AAC cohort(Cohort B)N=655N=327Gainp valueHGD7/655(1.0%)18/327 (5.5%)5.5 fold0.0001T1 Cancers3/655 (0.4%)14/327 (4.2%)10 fold0.0001Total10/655 (1.5%)32/327 (9.7%)6.5 fold0.0001ConclusionThis is the first report from a large exclusively Barrett's surveillance population. Our data demonstrates that acetic acid chromoscopy significantly (6.5 fold) improves the detection of high risk neoplasia in Barrett's surveillance as compared to the current standard of 2 cm quadrantic biopsies. AAC also results in significantly less number of biopsies taken so overall it will be very cost-effective. This questions the validity of the current standard of non targeted protocol guided biopsies during Barrett's surveillance.Disclosure of InterestNone Declared]]></description><identifier>ISSN: 0017-5749</identifier><identifier>DOI: 10.1136/gutjnl-2013-304907.045</identifier><language>eng</language><ispartof>Gut, 2013-06, Vol.62 (Suppl 1), p.A20-A21</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Bhattacharyya, R</creatorcontrib><creatorcontrib>Tholoor, S</creatorcontrib><creatorcontrib>Longcroft-Wheaton, G</creatorcontrib><creatorcontrib>Basford, P</creatorcontrib><creatorcontrib>Cowlishaw, D</creatorcontrib><creatorcontrib>Poller, D</creatorcontrib><creatorcontrib>Bhandari, P</creatorcontrib><title>OC-046Acetic Acid Chromoscopy Significantly Improves Neoplasia Detection Rates as compared to Cleveland Clinic Protocol during Barrett'S Surveillance</title><title>Gut</title><description><![CDATA[IntroductionCost effectiveness of Barrett's surveillance has recently being questioned due to the low neoplasia detection rate. Acetic acid chromoscopy (AAC) has been shown to improve neoplasia detection in Barrett's oesophagus but not in surveillance population. The aim of this study is to compare the effectiveness of AAC with Cleveland clinic protocol (2 cm quadrantic) guided biopsies at detecting high risk neoplasia during Barrett's surveillance.MethodsProspective Cohort study comparing two different Barrett's surveillance strategies. All patients who underwent Barrett's surveillance between 2008-12 were recorded on a Barrett's database. All neoplasias were independently reviewed by two GI Pathologists. Barrett's surveillance patients were randomly allocated to acetic acid chromoscopy lists (cohort B) or protocol guided biopsy (Cohort A) lists. AAC involved targeted biopsy of area of concern & 3 additional biopsies from lower, middle & top end of Barrett's. Protocol guided were taken as quadrantic biopsies every 2 cm & any visible abnormality. Fisher's exact test was used for statistical analysis.ResultsN = 982 Barrett's surveillance gastroscopy between 2008-12. Median age was 66 years & Median Barrett's length was 4.5 cm (range: 1-20). Male: Female = 3.3:1.Protocol guided Cohort AN = 655/982(66.7%). 7/655 (1%) patients were found to have high grade dysplasia (HGD) & 3/655(0.4%) had T-1 cancers with an overall high risk neoplasia detection rate of 10/655(1.5%).Acetic acid Cohort BN = 327/982(33.2%). 18/327(5.5%) patients were found to have HGD & 14/327(4.2%) had T-1 cancers with an overall high risk neoplasia detection rate of 32/327(9.7%). This shows a statistically significant 6.5 fold (p = 0.0001) increased detection of high risk neoplasia with acetic acid guided biopsies as compared to protocol guided biopsies in Barrett's surveillance.Abstract OC-046 Table 1Protocol biopsies cohort(Cohort A)AAC cohort(Cohort B)N=655N=327Gainp valueHGD7/655(1.0%)18/327 (5.5%)5.5 fold0.0001T1 Cancers3/655 (0.4%)14/327 (4.2%)10 fold0.0001Total10/655 (1.5%)32/327 (9.7%)6.5 fold0.0001ConclusionThis is the first report from a large exclusively Barrett's surveillance population. Our data demonstrates that acetic acid chromoscopy significantly (6.5 fold) improves the detection of high risk neoplasia in Barrett's surveillance as compared to the current standard of 2 cm quadrantic biopsies. AAC also results in significantly less number of biopsies taken so overall it will be very cost-effective. This questions the validity of the current standard of non targeted protocol guided biopsies during Barrett's surveillance.Disclosure of InterestNone Declared]]></description><issn>0017-5749</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqVjTtOxDAURV2AxPDZAnodNB5s4vzKIYCgAUToR5bzJnjk-AXbiTQLYb8EiQ1Q3eIencPYpRRrKbPipp_S3jt-K2TGM6FqUa6Fyo_YSghZ8rxU9Qk7jXEvhKiqWq7Y92vDhSo2BpM1sDG2g-Yz0EDR0HiA1vbe7qzRPrkDPA9joBkjvCCNTker4R4TmmTJw7tOy6MjGBpGHbCDRNA4nNFpv1id9UvhLVAiQw66KVjfw50OAVO6aqGdwozWLbDBc3a80y7ixd-esevHh4_miS_9rwlj2g42GvyFkaa4lWWeqaJSucr-gf4Ak_Zi3g</recordid><startdate>20130601</startdate><enddate>20130601</enddate><creator>Bhattacharyya, R</creator><creator>Tholoor, S</creator><creator>Longcroft-Wheaton, G</creator><creator>Basford, P</creator><creator>Cowlishaw, D</creator><creator>Poller, D</creator><creator>Bhandari, P</creator><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20130601</creationdate><title>OC-046Acetic Acid Chromoscopy Significantly Improves Neoplasia Detection Rates as compared to Cleveland Clinic Protocol during Barrett'S Surveillance</title><author>Bhattacharyya, R ; Tholoor, S ; Longcroft-Wheaton, G ; Basford, P ; Cowlishaw, D ; Poller, D ; Bhandari, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_17534684543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bhattacharyya, R</creatorcontrib><creatorcontrib>Tholoor, S</creatorcontrib><creatorcontrib>Longcroft-Wheaton, G</creatorcontrib><creatorcontrib>Basford, P</creatorcontrib><creatorcontrib>Cowlishaw, D</creatorcontrib><creatorcontrib>Poller, D</creatorcontrib><creatorcontrib>Bhandari, P</creatorcontrib><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Gut</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bhattacharyya, R</au><au>Tholoor, S</au><au>Longcroft-Wheaton, G</au><au>Basford, P</au><au>Cowlishaw, D</au><au>Poller, D</au><au>Bhandari, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>OC-046Acetic Acid Chromoscopy Significantly Improves Neoplasia Detection Rates as compared to Cleveland Clinic Protocol during Barrett'S Surveillance</atitle><jtitle>Gut</jtitle><date>2013-06-01</date><risdate>2013</risdate><volume>62</volume><issue>Suppl 1</issue><spage>A20</spage><epage>A21</epage><pages>A20-A21</pages><issn>0017-5749</issn><abstract><![CDATA[IntroductionCost effectiveness of Barrett's surveillance has recently being questioned due to the low neoplasia detection rate. Acetic acid chromoscopy (AAC) has been shown to improve neoplasia detection in Barrett's oesophagus but not in surveillance population. The aim of this study is to compare the effectiveness of AAC with Cleveland clinic protocol (2 cm quadrantic) guided biopsies at detecting high risk neoplasia during Barrett's surveillance.MethodsProspective Cohort study comparing two different Barrett's surveillance strategies. All patients who underwent Barrett's surveillance between 2008-12 were recorded on a Barrett's database. All neoplasias were independently reviewed by two GI Pathologists. Barrett's surveillance patients were randomly allocated to acetic acid chromoscopy lists (cohort B) or protocol guided biopsy (Cohort A) lists. AAC involved targeted biopsy of area of concern & 3 additional biopsies from lower, middle & top end of Barrett's. Protocol guided were taken as quadrantic biopsies every 2 cm & any visible abnormality. Fisher's exact test was used for statistical analysis.ResultsN = 982 Barrett's surveillance gastroscopy between 2008-12. Median age was 66 years & Median Barrett's length was 4.5 cm (range: 1-20). Male: Female = 3.3:1.Protocol guided Cohort AN = 655/982(66.7%). 7/655 (1%) patients were found to have high grade dysplasia (HGD) & 3/655(0.4%) had T-1 cancers with an overall high risk neoplasia detection rate of 10/655(1.5%).Acetic acid Cohort BN = 327/982(33.2%). 18/327(5.5%) patients were found to have HGD & 14/327(4.2%) had T-1 cancers with an overall high risk neoplasia detection rate of 32/327(9.7%). This shows a statistically significant 6.5 fold (p = 0.0001) increased detection of high risk neoplasia with acetic acid guided biopsies as compared to protocol guided biopsies in Barrett's surveillance.Abstract OC-046 Table 1Protocol biopsies cohort(Cohort A)AAC cohort(Cohort B)N=655N=327Gainp valueHGD7/655(1.0%)18/327 (5.5%)5.5 fold0.0001T1 Cancers3/655 (0.4%)14/327 (4.2%)10 fold0.0001Total10/655 (1.5%)32/327 (9.7%)6.5 fold0.0001ConclusionThis is the first report from a large exclusively Barrett's surveillance population. Our data demonstrates that acetic acid chromoscopy significantly (6.5 fold) improves the detection of high risk neoplasia in Barrett's surveillance as compared to the current standard of 2 cm quadrantic biopsies. AAC also results in significantly less number of biopsies taken so overall it will be very cost-effective. This questions the validity of the current standard of non targeted protocol guided biopsies during Barrett's surveillance.Disclosure of InterestNone Declared]]></abstract><doi>10.1136/gutjnl-2013-304907.045</doi></addata></record>
fulltext fulltext
identifier ISSN: 0017-5749
ispartof Gut, 2013-06, Vol.62 (Suppl 1), p.A20-A21
issn 0017-5749
language eng
recordid cdi_proquest_miscellaneous_1753468454
source PubMed (Medline); BMJ Journals Online Archive
title OC-046Acetic Acid Chromoscopy Significantly Improves Neoplasia Detection Rates as compared to Cleveland Clinic Protocol during Barrett'S Surveillance
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T08%3A16%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=OC-046Acetic%20Acid%20Chromoscopy%20Significantly%20Improves%20Neoplasia%20Detection%20Rates%20as%20compared%20to%20Cleveland%20Clinic%20Protocol%20during%20Barrett'S%20Surveillance&rft.jtitle=Gut&rft.au=Bhattacharyya,%20R&rft.date=2013-06-01&rft.volume=62&rft.issue=Suppl%201&rft.spage=A20&rft.epage=A21&rft.pages=A20-A21&rft.issn=0017-5749&rft_id=info:doi/10.1136/gutjnl-2013-304907.045&rft_dat=%3Cproquest%3E1753468454%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1753468454&rft_id=info:pmid/&rfr_iscdi=true